150 related articles for article (PubMed ID: 2849975)
1. c-erbB-2 expression in benign and malignant breast disease.
Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Elliott C; Ashley S; Monaghan P; Harrison S
Br J Cancer; 1988 Oct; 58(4):453-7. PubMed ID: 2849975
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
Somerville JE; Clarke LA; Biggart JD
J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789
[TBL] [Abstract][Full Text] [Related]
3. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 expression in different histological types of invasive breast carcinoma.
Soomro S; Shousha S; Taylor P; Shepard HM; Feldmann M
J Clin Pathol; 1991 Mar; 44(3):211-4. PubMed ID: 1672872
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer.
Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Price P; McKinna A; Harrison S
Int J Cancer; 1988 Dec; 42(6):842-5. PubMed ID: 2903851
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
7. [Study of c-erbB-2 expression in breast neoplasms].
Ye F
Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):104-6. PubMed ID: 8104720
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.
Barnes DM; Lammie GA; Millis RR; Gullick WL; Allen DS; Altman DG
Br J Cancer; 1988 Oct; 58(4):448-52. PubMed ID: 2849974
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.
Maguire HC; Hellman ME; Greene MI; Yeh I
Pathobiology; 1992; 60(3):117-21. PubMed ID: 1352687
[TBL] [Abstract][Full Text] [Related]
12. C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma.
Heatley M; Maxwell P; Whiteside C; Toner PG
Pathol Res Pract; 1993 Apr; 189(3):261-6. PubMed ID: 7687354
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
[TBL] [Abstract][Full Text] [Related]
14. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
15. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE
Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663
[TBL] [Abstract][Full Text] [Related]
16. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
[TBL] [Abstract][Full Text] [Related]
17. Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
Schimmelpenning H; Eriksson ET; Falkmer UG; Azavedo E; Svane G; Auer GU
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):433-40. PubMed ID: 1350695
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of c-erbB-2 in human breast carcinomas.
Gusterson BA; Gullick WJ; Venter DJ; Powles TJ; Elliott C; Ashley S; Tidy A; Harrison S
Mol Cell Probes; 1987 Dec; 1(4):383-91. PubMed ID: 3330998
[TBL] [Abstract][Full Text] [Related]
19. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
